Pimobendan
![]() |
- ₹10825 - ₹46460.9
- Product name: Pimobendan
- CAS: 74150-27-9
- MF: C19H18N4O2
- MW: 334.37
- EINECS:640-420-7
- MDL Number:MFCD00761648
- Synonyms:4,5-dihydro-6-[2-(4-methoxyphenyl)-1h-benzimidazol-5-yl]-5-methyl-3(2h)-pyridazinone;6-(2-(4-methoxyphenyl)-1H-benzo[d]imidazol-6-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one;6-(2-(4-Methoxyphenyl)-4,5-dihydro-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone;Pimobendan [inn-spanish];Pimobendane;Pimobendane [inn-french];Pimobendanum;PiMobendan(VetMedin)
3 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 10MG
- 50MG
- 200MG
- ManufacturerSigma-Aldrich(India)
- Product numberSML1333
- Product descriptionPimobendan ≥98% (HPLC)
- Packaging10MG
- Price₹10825
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberSML1333
- Product descriptionPimobendan ≥98% (HPLC)
- Packaging50MG
- Price₹43613.93
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberPHR3084
- Product descriptionPimobendan pharmaceutical secondary standard, certified reference material
- Packaging200MG
- Price₹46460.9
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML1333 | Pimobendan ≥98% (HPLC) | 10MG | ₹10825 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | SML1333 | Pimobendan ≥98% (HPLC) | 50MG | ₹43613.93 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | PHR3084 | Pimobendan pharmaceutical secondary standard, certified reference material | 200MG | ₹46460.9 | 2022-06-14 | Buy |
Properties
Melting point :approximate 243℃ (dec.)
Density :1.36
storage temp. :2-8°C
solubility :DMSO: soluble5mg/mL, clear (warmed)
form :powder
pka :10.55±0.10(Predicted)
color :white to beige
InChI :InChI=1S/C19H18N4O2/c1-11-9-17(24)22-23-18(11)13-5-8-15-16(10-13)21-19(20-15)12-3-6-14(25-2)7-4-12/h3-8,10-11H,9H2,1-2H3,(H,20,21)(H,22,24)
InChIKey :GLBJJMFZWDBELO-UHFFFAOYSA-N
SMILES :C1(=O)NN=C(C2C=C3NC(C4=CC=C(OC)C=C4)=NC3=CC=2)C(C)C1
CAS DataBase Reference :74150-27-9(CAS DataBase Reference)
Density :1.36
storage temp. :2-8°C
solubility :DMSO: soluble5mg/mL, clear (warmed)
form :powder
pka :10.55±0.10(Predicted)
color :white to beige
InChI :InChI=1S/C19H18N4O2/c1-11-9-17(24)22-23-18(11)13-5-8-15-16(10-13)21-19(20-15)12-3-6-14(25-2)7-4-12/h3-8,10-11H,9H2,1-2H3,(H,20,21)(H,22,24)
InChIKey :GLBJJMFZWDBELO-UHFFFAOYSA-N
SMILES :C1(=O)NN=C(C2C=C3NC(C4=CC=C(OC)C=C4)=NC3=CC=2)C(C)C1
CAS DataBase Reference :74150-27-9(CAS DataBase Reference)
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|
Description
Pimobendan, a novel cardiotonic vasodilator, was introduced in Japan for the treatment of acute and mild to moderate chronic heart failure. It is a phosphodiesterase Ⅲ inhibitor and is able to enhance sensitization of myocardial contractile regulatory protein to calcium ions. The combination of these effects contribute to its inotropic activity. In patients with severe congestive heart failure, orally administered pimobendan improves cardiac index, stroke volume index, pulmonary wedge pressure, and systemic and pulmonary vascular resistance. Pimobendan is reported to be well tolerated and largely devoid of the proarrhythmic effects of classical phosphodiesterase Ill inhibitors. Studies also suggested that combination of the inotropic agent pimobendan with an ACE inhibitor such as enalapril may be superior to monotherapy for heart failure patients.More related product prices
SGX-523 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Selumetinib I-BET151 (GSK1210151A) Pimecrolimus Famciclovir Sildenafil Pimobendan 3(2H)-PyridazinoneRelated product price
- SGX-523
₹15469.99 - 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide
₹8045-32420 - I-BET151 (GSK1210151A)
₹15403.98-62633.45
Suppliers and manufacturers
Zenfold Sustainable Technologies (ZST)
A.J Chemicals
CLEARSYNTH LABS LTD.
CHEMSWORTH
SynZeal Research Pvt Ltd
Pharmaffiliates Analytics and Synthetics P. Ltd
Tianjin Kilo Pharmaceutical Sci-Tech Co., Ltd
Taizhou Creating Bio-pharm co., ltd.